Distinctions, labels and prizes

Accolades confirming the excellence of Genopole companies

Year 2024 illustrated how Genopole-accompanied businesses are able to distinguish themselves in the most-demanding competitions and national calls for proposals.

Of the 12 biocluster companies submitting a dossier for the i-Lab competition, four were awarded the i-Lab label: bYoRNA, CGenetix, endogene.bio and Fungu'it.

Three other Genopole companies convinced deciders in France 2030 calls for proposals, thus obtaining structuring support for their development: Adlin, Nutropy and ChromoDiag. These achievements demonstrate the solidity of the projects forwarded by Genopole companies and the innovation potential of these latter. They also attest to the quality of Genopole's accompaniment upstream of dossier submissions, aimed at guarantying future success.

A closer look... 4 laureates

Read the press release

endogene.bio has developed a technological platform to accelerate the identification of molecular biomarkers with the aim of refining diagnostics, better stratifying patients and optimizing key steps in novel therapeutics research.

bYoRNA is developing advanced bioengineering technologies for messenger RNAs to improve gene therapies and vaccines. Its i-Lab project valorized an innovative production technology.

ChromoDiag is a spin-off of Cell Environment, a beneficiary of Genopole programs. A France 2030 laureate, ChromoDiag is advancing a chromatin-based diagnostic technology for personalized therapies.

Nutropy develops sustainable cheese substitutes from precision fermented proteins. Their impactful project received France 2030 support in 2024.